ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	31/204	191/7206	1.03808471259e-15
ko05340	Primary immunodeficiency	14/204	30/7206	1.32913796468e-14
ko05164	Influenza A	27/204	167/7206	9.53240302276e-14
ko05168	Herpes simplex infection	28/204	182/7206	1.16109792121e-13
ko04621	NOD-like receptor signaling pathway	26/204	157/7206	1.58275516242e-13
ko04217	Necroptosis	27/204	178/7206	4.71537302622e-13
ko05162	Measles	22/204	120/7206	1.5792219204e-12
ko04380	Osteoclast differentiation	23/204	134/7206	2.02689868609e-12
ko04064	NF-kappa B signaling pathway	19/204	96/7206	1.38317922843e-11
ko04650	Natural killer cell mediated cytotoxicity	19/204	97/7206	1.67783935972e-11
ko04620	Toll-like receptor signaling pathway	19/204	100/7206	2.95114304987e-11
ko05145	Toxoplasmosis	20/204	126/7206	2.636681553e-10
ko04659	Th17 cell differentiation	18/204	106/7206	6.9555093562e-10
ko05152	Tuberculosis	23/204	187/7206	2.10884822742e-09
ko04612	Antigen processing and presentation	15/204	77/7206	2.7012386394e-09
ko05321	Inflammatory bowel disease (IBD)	13/204	56/7206	3.31582364678e-09
ko05320	Autoimmune thyroid disease	10/204	29/7206	3.32536283557e-09
ko05330	Allograft rejection	9/204	24/7206	8.86410617515e-09
ko05161	Hepatitis B	21/204	173/7206	1.40509962454e-08
ko05167	Kaposi's sarcoma-associated herpesvirus infection	22/204	191/7206	1.65794699533e-08
ko05140	Leishmaniasis	14/204	75/7206	1.66549622676e-08
ko04630	Jak-STAT signaling pathway	18/204	132/7206	2.58639545219e-08
ko04660	T cell receptor signaling pathway	17/204	124/7206	5.92767461582e-08
ko04658	Th1 and Th2 cell differentiation	15/204	96/7206	6.23072818205e-08
ko04622	RIG-I-like receptor signaling pathway	12/204	62/7206	1.19459597129e-07
ko05332	Graft-versus-host disease	7/204	18/7206	3.21190635216e-07
ko04672	Intestinal immune network for IgA production	9/204	37/7206	6.12425225474e-07
ko04623	Cytosolic DNA-sensing pathway	9/204	41/7206	1.56318515608e-06
ko04940	Type I diabetes mellitus	8/204	32/7206	2.10845523088e-06
ko05142	Chagas disease (American trypanosomiasis)	15/204	130/7206	3.44353305371e-06
ko04062	Chemokine signaling pathway	19/204	201/7206	3.53485509516e-06
ko04668	TNF signaling pathway	14/204	120/7206	6.46578170361e-06
ko04210	Apoptosis	17/204	180/7206	1.19330088622e-05
ko05160	Hepatitis C	15/204	153/7206	2.54329364882e-05
ko05133	Pertussis	11/204	87/7206	3.04113863025e-05
ko04662	B cell receptor signaling pathway	11/204	88/7206	3.39062393738e-05
ko05310	Asthma	5/204	17/7206	8.11610131265e-05
ko03050	Proteasome	8/204	54/7206	0.000122143183584
ko04145	Phagosome	14/204	162/7206	0.00018703591973
ko04664	Fc epsilon RI signaling pathway	9/204	77/7206	0.000298027355837
ko04640	Hematopoietic cell lineage	8/204	64/7206	0.000407823527306
ko05150	Staphylococcus aureus infection	6/204	36/7206	0.00045804202114
ko05166	HTLV-I infection	19/204	292/7206	0.000770242632405
ko05144	Malaria	6/204	45/7206	0.00155020286711
ko05169	Epstein-Barr virus infection	14/204	206/7206	0.00205344432751
ko04080	Neuroactive ligand-receptor interaction	3/204	423/7206	0.00355679673174
ko05323	Rheumatoid arthritis	8/204	89/7206	0.00356243316839
ko05416	Viral myocarditis	6/204	55/7206	0.00436664234028
ko05134	Legionellosis	7/204	74/7206	0.00475226017665
ko04611	Platelet activation	11/204	163/7206	0.00640083288471
ko04610	Complement and coagulation cascades	7/204	79/7206	0.00680068408616
ko04666	Fc gamma R-mediated phagocytosis	9/204	122/7206	0.00755786114671
ko04670	Leukocyte transendothelial migration	10/204	151/7206	0.0103968258354
ko05120	Epithelial cell signaling in Helicobacter pylori infection	7/204	92/7206	0.0151286532422
ko05146	Amoebiasis	7/204	99/7206	0.0218152207601
ko05131	Shigellosis	6/204	82/7206	0.0282284708986
ko00966	Glucosinolate biosynthesis	1/204	1/7206	0.0283097418817
ko04514	Cell adhesion molecules (CAMs)	8/204	130/7206	0.0308436107494
ko00511	Other glycan degradation	3/204	26/7206	0.0360153790516